Kewaunee Scientific (NASDAQ:KEQU) CEO Sells $39,000.00 in Stock

Kewaunee Scientific Corporation (NASDAQ:KEQU) CEO Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock in a transaction that occurred on Monday, December 22nd. The shares were sold at an average price of $39.00, for a total value of $39,000.00. Following the completion of the sale, the chief executive officer owned 36,719 shares in the company, valued at approximately $1,432,041. This trade represents a 2.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.

Thomas David Hull III also recently made the following trade(s):

• On Wednesday, October 1st, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.09, for a total transaction of $43,090.00.
• On Monday, September 29th, Thomas David Hull III sold 1,854 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.42, for a total value of $80,500.68.
• On Wednesday, September 24th, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.62, for a total transaction of $43,620.00.

Kewaunee Scientific Stock Performance

Shares of NASDAQ KEQU opened at $38.72 on Tuesday. The company has a 50-day simple moving average of $40.58 and a 200-day simple moving average of $47.02. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.48 and a quick ratio of 1.71. The company has a market cap of $111.13 million, a PE ratio of 9.83 and a beta of 0.61. Kewaunee Scientific Corporation has a 12 month low of $30.33 and a 12 month high of $71.33.

Kewaunee Scientific (NASDAQ:KEQU) last announced its earnings results on Wednesday, December 10th. The technology company reported $0.91 earnings per share (EPS) for the quarter. The firm had revenue of $70.10 million for the quarter. Kewaunee Scientific had a net margin of 4.11% and a return on equity of 22.39%. During the same quarter last year, the business posted $1.01 EPS.

Analyst Ratings Changes

A number of equities research analysts have issued reports on KEQU shares. Wall Street Zen downgraded Kewaunee Scientific from a “buy” rating to a “hold” rating in a research report on Saturday, December 13th. Weiss Ratings restated a “hold (c+)” rating on shares of Kewaunee Scientific in a report on Wednesday, October 8th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Kewaunee Scientific currently has a consensus rating of “Hold”.

Hedge Funds Weigh In On Kewaunee Scientific

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Susquehanna International Group LLP purchased a new position in Kewaunee Scientific in the 3rd quarter worth approximately $713,000. Punch & Associates Investment Management Inc. boosted its stake in shares of Kewaunee Scientific by 61.9% in the third quarter. Punch & Associates Investment Management Inc. now owns 70,085 shares of the technology company’s stock valued at $2,989,000 after purchasing an additional 26,785 shares during the period. Mink Brook Asset Management LLC grew its holdings in Kewaunee Scientific by 83.4% during the 3rd quarter. Mink Brook Asset Management LLC now owns 11,571 shares of the technology company’s stock valued at $494,000 after purchasing an additional 5,261 shares in the last quarter. Minerva Advisors LLC increased its stake in Kewaunee Scientific by 3.7% during the 3rd quarter. Minerva Advisors LLC now owns 80,274 shares of the technology company’s stock worth $3,424,000 after buying an additional 2,832 shares during the period. Finally, Royce & Associates LP acquired a new position in Kewaunee Scientific in the 3rd quarter worth $1,663,000. 32.69% of the stock is owned by institutional investors and hedge funds.

About Kewaunee Scientific

Kewaunee Scientific Corporation (NASDAQ:KEQU) is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.

The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.